Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline ...

The Company has received FDA approval for its first system, LungFit ® PH, for the treatment of term and near-term neonates with hypoxic respiratory ... of biological functions. In the airways, NO ...

executive Andrew Witty Thursday said the U.S. healthcare system “needs to function better” and that his company’s mission was to “help people live healthier lives.” In this photo ...